BDBM496835 SARS-CoV-2 PLpro Inhibitor, 65::US20240166598, Compound ZN-3-80

SMILES C[C@@H](NC(=O)c1cc(NC2CNC2)ccc1C)c1cccc(c1)-c1cccs1

InChI Key InChIKey=FMPUADOXTPMTON-MRXNPFEDSA-N

Data  4 IC50  3 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 496835   

TargetReplicase polyprotein 1ab(2019-nCoV)
University of Illinois At Chicago

LigandPNGBDBM496835(SARS-CoV-2 PLpro Inhibitor, 65 | US20240166598, Co...)
Affinity DataIC50:  590nMAssay Description:The PLpro primary assay, which measures protease activity with the short peptide substrate Z-RLRGG-AMC (Bachem), was performed in black flat-bottom 3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed

TargetReplicase polyprotein 1ab(2019-nCoV)
University of Illinois At Chicago

LigandPNGBDBM496835(SARS-CoV-2 PLpro Inhibitor, 65 | US20240166598, Co...)
Affinity DataKd:  963nMAssay Description:The His-tagged SARS-CoV-2 PLpro enzyme was initially prepared in phosphate buffer and diluted to 50 ug/mL with 10 mM sodium acetate (pH 5.5) and immo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed

TargetReplicase polyprotein 1ab(2019-nCoV)
University of Illinois At Chicago

LigandPNGBDBM496835(SARS-CoV-2 PLpro Inhibitor, 65 | US20240166598, Co...)
Affinity DataIC50:  590nMAssay Description:Inhibition of SARS-CoV-2 PLproMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed

TargetReplicase polyprotein 1a [1564-1878](Severe acute respiratory syndrome coronavirus (SAR...)
Arizona Board of Regents on Behalf of the University of Arizona; The Board of Trustees of the University of Illinois

US Patent
LigandPNGBDBM496835(SARS-CoV-2 PLpro Inhibitor, 65 | US20240166598, Co...)
Affinity DataKd:  963nMAssay Description:The His-tagged SARS-CoV-2 PLpro enzyme was initially prepared in phosphate buffer and diluted to 50 pg/mL with 10 mM sodium acetate (pH 5.5) and immo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetReplicase polyprotein 1a(2019-nCoV)
Arizona Board of Regents on Behalf of the University of Arizona; The Board of Trustees of the University of Illinois

US Patent
LigandPNGBDBM496835(SARS-CoV-2 PLpro Inhibitor, 65 | US20240166598, Co...)
Affinity DataKd:  2.70E+3nMAssay Description:The PLpro primary assay using PLpro as prepared above was conducted as described below and provided the data described in Table 7 in the column: Enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetReplicase polyprotein 1a [1564-1878](Severe acute respiratory syndrome coronavirus (SAR...)
Arizona Board of Regents on Behalf of the University of Arizona; The Board of Trustees of the University of Illinois

US Patent
LigandPNGBDBM496835(SARS-CoV-2 PLpro Inhibitor, 65 | US20240166598, Co...)
Affinity DataIC50:  590nMAssay Description:The His-tagged SARS-CoV-2 PLpro enzyme was initially prepared in phosphate buffer and diluted to 50 pg/mL with 10 mM sodium acetate (pH 5.5) and immo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetReplicase polyprotein 1a(2019-nCoV)
Arizona Board of Regents on Behalf of the University of Arizona; The Board of Trustees of the University of Illinois

US Patent
LigandPNGBDBM496835(SARS-CoV-2 PLpro Inhibitor, 65 | US20240166598, Co...)
Affinity DataIC50:  650nMAssay Description:The PLpro primary assay using PLpro as prepared above was conducted as described below and provided the data described in Table 7 in the column: Enzy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent